Section 558.322 - Standards for Alternate Delivery Sites(a) An ADS must comply with the Statute and this chapter, including the additional standards in Subchapter H of this chapter (relating to Standards Specific to Agencies Licensed to Provide Hospice Services).(b) If certified by CMS, an ADS must comply with the applicable federal rules and regulations for hospice agencies in 42 CFR Part 418.(c) A parent agency and an ADS must meet the following requirements: (1) The parent agency administrator or alternate administrator, or supervising nurse or alternate supervising nurse, must conduct an on-site supervisory visit to the ADS at least monthly. The parent agency may visit the ADS more frequently considering the size of the service area provided by the parent agency. The supervisory visits must be documented and include the date of the visit, the content of the consultation, the individuals in attendance, and the recommendations of the staff.(2) The parent agency must approve all ADS policies and procedures. This approval must be documented and filed in the parent agency and ADS.(d) Issuance or renewal of an ADS license is contingent upon compliance by the parent agency and ADS with the Statute and this chapter. (1) HHSC may take enforcement action against a parent agency license for an ADS' failure to comply with the Statute or this chapter in accordance with Subchapter F of this chapter (relating to Enforcement).(2) Revocation, suspension, denial or surrender of a parent agency license results in the same revocation, suspension, denial or surrender of all ADS licenses of the parent agency.26 Tex. Admin. Code § 558.322
The provisions of this §558.322 adopted to be effective February 1, 2002, 26 TexReg 9159; amended to be effective June 1, 2006, 31 TexReg 1455; amended to be effective October 1, 2013, 38 TexReg 6628; Transferred from Title 40, Chapter 97 by Texas Register, Volume 44, Number 15, April 12, 2019, TexReg 1893, eff. 5/1/2019; Amended by Texas Register, Volume 46, Number 15, April 9, 2021, TexReg 2431, eff. 4/25/2021